Contact

Click here for a confidential contact or call:

1-212-350-2774

FCA Federal

This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:

Page 124 of 182

Two Bay Area Companies for Developmentally Disabled Settle Whistleblower Charges of Overbilling

Posted  08/29/17
By the C|C Whistleblower Lawyer Team Two Bay Area companies and their owners agreed to pay roughly $2 million to settle charges they violated the False Claims Act by overbilling the government in a program designed to serve Californians with developmental disabilities. The government, and the whistleblower who originated the action -- Beverly McCaffery -- alleged that Alternative Learning Center, its president...

Eye Surgery Provider Settles FCA Kickback Allegations for $12M

Posted  08/23/17
By the C|C Whistleblower Lawyer Team Sightpath Medical, Inc., its parent TLC Vision Corp., and its former CEO James Tiffany have agreed to pay $12 million to resolve allegations, originally brought by a whistleblower, that they defrauded the government by billing it for eye surgery products and services tainted by illegal kickbacks to physicians. According to the Justice Department’s press release, Sightpath...

In Their Own Words -- Weinreb

Posted  08/21/17

--“Taxpayers rightly expect companies like Mylan that receive payments from taxpayer-funded programs to scrupulously follow the rules. We will continue to protect the integrity of Medicaid and ensure a level playing field for pharmaceutical companies. ”

Statement of Acting United States Attorney William D. Weinreb commenting on the $465 million settlement in an FCA case against Mylan Inc.

DOJ Catch of the Week -- Mylan

Posted  08/18/17
By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Mylan Inc. and Mylan Specialty L.P. Yesterday, the pharmaceutical companies agreed to pay $465 million to settle charges they violated the False Claims Act by purposely misclassifying EpiPen as a generic drug to avoid paying higher Medicaid rebates. In announcing the settlement, the government stressed its "unwavering...

August 15, 2017

Posted  08/15/17
Bryon Faulkner, former employee of Virginia-based Huntington Ingalls Industries Inc., will receive a whistleblower award of roughly $1.6 million from the $9.2 million the company agreed to pay to settle charges it violated the False Claims Act by knowingly overbilling the government for labor on U.S. Navy and Coast Guard ships at its shipyards in Pascagoula, Mississippi. DOJ

Mortgage Fraud Whistleblower Gets Over $9 Million

Posted  08/9/17
By the C|C Whistleblower Lawyer Team Yesterday, the U.S. Department of Justice (DOJ) announced a nearly $75 million settlement with PHH Mortgage Corporation regarding the company’s failure to meet origination, underwriting, and quality-control regulations promulgated by Department of Housing and Urban Development’s (HUD) Federal Housing Administration (FHA), the U.S. Department of Veterans Affairs, the Federal...

August 2, 2017

Atlanta-based pain management clinic Atlanta Medical Clinic and its owner Dr. Timothy Dembowski agreed to pay $250,000 to resolve charges they violated the False Claims Act by billing for services performed by a physician suspended from the Medicare program and administering foreign, non-FDA approved drugs, which are not eligible for reimbursement under the Medicare program.  DOJ (NDGA)

July 24, 2017

Dr. James Norman, the owner and operator of Norman Parathyroid Center, agreed to pay $4 million to resolve allegations he violated the False Claims Act by billing Medicare for pre-operative examination services for which he had already received payment from the government.  These extra fees ranged from $150 to $750 for Florida residents, to $1,750 or more for patients who lived out-of-state, adding up to hundreds of thousands of dollars in illicit billing.  The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a former patient of Dr. Norman, Myra Gross, and her husband, Dr. David Gross.  They will receive a whistleblower award of roughly $600,000 from the proceeds of the government's recovery.  DOJ (MDFL)

July 14, 2017

Narco Freedom, Inc., a former operator of outpatient chemical dependency clinics, Joining Hands Management Inc., an operator of short-term residences known as “three-quarter houses,” and Joining Hands co-owner Devorah Haigler, settled claims of violating the False Claims Act.  The government will receive a $50.5 million allowed claim in the Narco Freedom bankruptcy proceeding, and Joining Hands and Haigler will pay $300,000.  The government alleged the defendants engaged in a kickback scheme whereby Narco made monthly cash payments to Joining Hands in exchange for Haigler and others referring residents of Joining Hands three-quarter houses to NARCO outpatient programs.  The allegations originated in a whistleblower lawsuit under the qui tam provisions of the False Claims Act.  An unidentified whistleblower will receive an undisclosed whistleblower award from the proceeds of the government's recovery.  DOJ (SDNY)
1 122 123 124 125 126 182